Mallinckrodt Hospital Products Inc.
Mallinckrodt Hospital Products Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 7 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0340-2024, Class II) was initiated on February 6, 2024.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 7
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0340-2024 | Class II | Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-do | February 6, 2024 |
| D-0341-2024 | Class II | Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Malli | February 6, 2024 |